4‐PBA initiates cancer stem cells by activating the PPARα‐dependent Wnt5b‐Fzd5‐β‐catenin signalling pathway, promoting the early occurrence of HCC. The gene discussed is PPARA; the disease is hepatocellular carcinoma.